Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

17 January 2024: Review Articles

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

Anna Bednarek 1ACEFG* , Marzena Laskowska 2E

DOI: 10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

Table 2 Vaccinations recommended for pregnant women and during breastfeeding [8,9,10,26].

Type of vaccinationTrimester of pregnancyRecommendations for vaccination according to local arrangements
dTpa (combined vaccine against diphtheria, tetanus, and pertussis)III, optimally 28–32 weeks of pregnancy1 dose, independent of previous vaccination
FluRegardless of the age of the pregnancy, 2 and 3 recommended1 dose of inactivated vaccine
COVID-19* Regardless of the age of pregnancy1 dose, if the previous one was given ≥6 months earlier, to protect the pregnant woman, fetus, and infant in the first 6 months of age
dTpa – combined vaccine containing tetanus toxoid and reduced doses of diphtheria toxoid and acellular pertussis antigens.
* Vaccines mRNA with updated composition, containing additionally coding mRNA.
S-protein of subvariant BA.1–2 or BA.4–5 Omicron; as recommended in June 2023, in the upcoming 2023/2024 season, drug regulatory bodies, the European Centre for Disease Prevention and Control; The ECDC, and the WHO recommend monovalent vaccines and the inclusion of XBB subvariant.1.5.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750